Q1 FY27 — 13 Aug 2026
Suraksha Diagnostic Limited Q1 FY27
Suraksha Diagnostic Limited reported a strong Q1 FY27, with robust revenue growth of 21% and significant PAT growth of 40%. Margin expansion was noted across both mature and newer centers, with the latter turning profitable. The genomics segment showed exceptional growth, and the company continued its network expansion strategy into new geographies while focusing on operational efficiencies.
Read the full call






